In particular, Holmström et al. have well disclosed the existence of protective “MPN-specific” T lymphocytes, selectively targeted against transformed cells carrying JAK2V617F and CALR exon 9 mutations [128,129,130]. This evidence concerns the gene CALR and myeloproliferative neoplasm.